A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4178 (2006.01) A61K 9/14 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61K 31/138 (2006.01) A61K 31/341 (2006.01) A61K 31/401 (2006.01) A61K 31/415 (2006.01) A61K 31/4422 (2006.01) A61K 31/54 (2006.01) A61K 31/549 (2006.01) A61K 31/635 (2006.01)
Patent
CA 2338256
This invention relates to bioenhanced formulations comprising eprosartan or eprosartan mesylate in the amorphous form, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
L'invention concerne des formulations bioaméliorées comprenant de l'eprosartane ou du mésylate d'eprosartane sous forme amorphe. L'invention concerne également un procédé de fabrication du composé selon l'invention, des compositions contenant le composé selon l'invention et des méthodes d'utilisation du composé selon l'invention afin de bloquer les récepteurs d'angiotensine II et de traiter l'hypertension, l'insuffisance cardiaque globale et l'insuffisance rénale.
Gudipati Manga R.
Venkatesh Gopadi
Glaxosmithkline Llc
Gowling Lafleur Henderson Llp
Smithkline Beecham Corporation
LandOfFree
Bioenhanced formulations comprising eprosartan in oral solid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bioenhanced formulations comprising eprosartan in oral solid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioenhanced formulations comprising eprosartan in oral solid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1458379